-
1
Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment
Published 2023-08-01Subjects: Get full text
Article -
2
Twenty-Years of Experience in Childhood Glaucoma Surgery
Published 2021-12-01Subjects: “…glaucoma…”
Get full text
Article -
3
Antibody and Protein Profiles in Glaucoma: Screening of Biomarkers and Identification of Signaling Pathways
Published 2021-12-01Subjects: Get full text
Article -
4
A generalizable deep learning regression model for automated glaucoma screening from fundus images
Published 2023-06-01“…Abstract A plethora of classification models for the detection of glaucoma from fundus images have been proposed in recent years. …”
Get full text
Article -
5
A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma
Published 2022-04-01Subjects: “…glaucoma…”
Get full text
Article -
6
Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study
Published 2023-02-01“…Objective To evaluate the long-term outcomes of trabeculectomy (TE) surgery in a large cohort with a minimum follow-up of 3 years.Design Retrospective cohort study.Setting University Eye Hospital, Germany.Participants Three hundred and seventy-nine patients with open-angle glaucoma underwent TE with mitomycin C (MMC) between January 2013 and February 2017 with a minimal follow-up of 3 years. …”
Get full text
Article -
7
Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma
Published 2022-11-01Subjects: “…glaucoma…”
Get full text
Article -
8
Influence of different primary surgical techniques on long-term intraocular pressure and medication in glaucoma after congenital cataract surgery.
Published 2023-01-01“…<h4>Purpose</h4>To assess long-time results of primary surgical treatment in children with glaucoma after congenital cataract surgery.<h4>Methods</h4>A retrospective study of 37 eyes from 35 children with glaucoma after congenital cataract surgery, who underwent surgery between 2011 and 2021 at the Childhood Glaucoma Center, University Medical Center Mainz, Germany. …”
Get full text
Article -
9
Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1
Published 2022-10-01Subjects: “…glaucoma…”
Get full text
Article -
10
Glaucoma-Associated CDR1 Peptide Promotes RGC Survival in Retinal Explants through Molecular Interaction with Acidic Leucine Rich Nuclear Phosphoprotein 32A (ANP32A)
Published 2023-07-01Subjects: “…glaucoma…”
Get full text
Article -
11
Muscarinic Acetylcholine Receptors in the Retina—Therapeutic Implications
Published 2021-05-01Subjects: Get full text
Article -
12
Oxidative Stress: A Suitable Therapeutic Target for Optic Nerve Diseases?
Published 2023-07-01Subjects: Get full text
Article -
13
Short-Term Omega-3 Supplementation Modulates Novel Neurovascular and Fatty Acid Metabolic Proteome Changes in the Retina and Ophthalmic Artery of Mice with Targeted <i>Cyp2c44</i>...
Published 2022-11-01“…The potential adjunct use of ω-3 PUFA for glaucoma therapy needs further investigation.…”
Get full text
Article -
14
Methods to measure blood flow and vascular reactivity in the retina
Published 2023-01-01“…Disturbances of retinal perfusion are involved in the onset and maintenance of several ocular diseases, including diabetic retinopathy, glaucoma, and retinal vascular occlusion. Hence, knowledge on ocular vascular anatomy and function is highly relevant for basic research studies and for clinical judgment and treatment. …”
Get full text
Article -
15
Measurement of Retrobulbar Blood Flow and Vascular Reactivity—Relevance for Ocular and Cardiovascular Diseases
Published 2023-11-01“…Abnormal retrobulbar hemodynamics have been linked to the development of various ocular diseases, including glaucoma, age-related macular degeneration, and diabetic retinopathy. …”
Get full text
Article -
16
Regulation of the HTRA2 Protease Activity by an Inhibitory Antibody-Derived Peptide Ligand and the Influence on HTRA2-Specific Protein Interaction Networks in Retinal Tissues
Published 2021-08-01“…In accordance with this, our group verified in a recent study that the synthetic peptide ASGYTFTNYGLSWVR, encoding the hypervariable sequence part of an antibody, showed a high affinity for the target protein HTRA2 and triggered neuroprotection in an in vitro organ culture model for glaucoma. To unravel this neuroprotective mechanism, the present study showed for the first time that the synthetic CDR1 peptide significantly (<i>p</i> < 0.01) inhibited the proteolytic activity of HTRA2 up to 50% using a specific protease function assay. …”
Get full text
Article